Dermata Therapeutics, Inc. (DRMA)Healthcare | Biotechnology | San Diego, United States | NasdaqCM
1.34 USD
-0.12
(-8.219%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.34 |
Hot Take ↕ | Aug. 22, 2026, 3:56 a.m. EDT
The immediate outlook is neutral-to-slightly-bearish despite a recent price bounce, as the stock remains trapped below key moving averages and faces significant dilution risks from recent private placements. The long-term investment case is effectively zero; the business has suffered a catastrophic multi-year decline with four consecutive years of negative annual returns, erasing nearly 99.95% of its value since 2021, which signals severe structural deterioration rather than a temporary setback. There is no dividend income to offset these fundamental flaws, making this a speculative biotech play with no safety margin. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.124117 |
| AutoETS | 0.124224 |
| MSTL | 0.127222 |
| AutoARIMA | 0.127588 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 3.43 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.936 |
| Excess Kurtosis | -0.09 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 6,639,977 |
| Forward P/E | -0.35 |
| Beta | 0.66 |
| Website | https://www.dermatarx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.7473611 |
| Address1 | 3,525 Del Mar Heights Rd. |
| Address2 | Suite 332 |
| All Time High | 16,680.0 |
| All Time Low | 0.951 |
| Ask | 1.74 |
| Ask Size | 2 |
| Average Analyst Rating | 2.0 - Buy |
| Average Daily Volume10 Day | 183,840 |
| Average Daily Volume3 Month | 753,672 |
| Average Volume | 753,672 |
| Average Volume10Days | 183,840 |
| Beta | 0.663 |
| Bid | 1.08 |
| Bid Size | 2 |
| Book Value | 0.867 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.34 |
| Current Ratio | 2.813 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.58 |
| Day Low | 1.34 |
| Display Name | Dermata Therapeutics |
| Earnings Timestamp End | 1,747,225,800 |
| Earnings Timestamp Start | 1,747,225,800 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 976,907 |
| Eps Forward | -3.87 |
| Eps Trailing Twelve Months | -3.83 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.3108 |
| Fifty Day Average Change | 0.029200077 |
| Fifty Day Average Change Percent | 0.022276532 |
| Fifty Two Week Change Percent | -74.736115 |
| Fifty Two Week High | 6.225 |
| Fifty Two Week High Change | -4.8849998 |
| Fifty Two Week High Change Percent | -0.7847389 |
| Fifty Two Week Low | 0.951 |
| Fifty Two Week Low Change | 0.38900006 |
| Fifty Two Week Low Change Percent | 0.4090432 |
| Fifty Two Week Range | 0.951 - 6.225 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,628,861,400,000 |
| Float Shares | 3,468,093 |
| Forward Eps | -3.87 |
| Forward P E | -0.34625325 |
| Free Cashflow | -5,110,870 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 9 |
| Fullday Change | -0.12 |
| Fullday Change Percent | -8.21918 |
| Fullday Price | 1.34 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.27354 |
| Held Percent Institutions | 0.07773 |
| Implied Shares Outstanding | 4,955,207 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-08-13 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,754,006,400 |
| Last Split Factor | 1:10 |
| Long Business Summary | Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California. |
| Long Name | Dermata Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 6,639,977 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_283634456 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -8,368,646 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,284,154 |
| Number Of Analyst Opinions | 1 |
| Open | 1.47 |
| Operating Cashflow | -8,034,258 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 858 800 2543 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.34 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 1.46 |
| Price Hint | 4 |
| Price To Book | 1.5455595 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.407 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.0 |
| Region | US |
| Regular Market Change | -0.12 |
| Regular Market Change Percent | -8.21918 |
| Regular Market Day High | 1.58 |
| Regular Market Day Low | 1.34 |
| Regular Market Day Range | 1.34 - 1.58 |
| Regular Market Open | 1.47 |
| Regular Market Previous Close | 1.46 |
| Regular Market Price | 1.34 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 102,243 |
| Return On Assets | -0.89884 |
| Return On Equity | -1.83886 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,955,207 |
| Shares Percent Shares Out | 0.0912 |
| Shares Short | 366,825 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 64,856 |
| Short Name | Dermata Therapeutics, Inc. |
| Short Percent Of Float | 0.1164 |
| Short Ratio | 0.21 |
| Source Interval | 15 |
| State | CA |
| Symbol | DRMA |
| Target High Price | 4.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 4.0 |
| Target Median Price | 4.0 |
| Total Cash | 4,412,764 |
| Total Cash Per Share | 1.097 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.83 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.65283 |
| Two Hundred Day Average Change | -0.31282997 |
| Two Hundred Day Average Change Percent | -0.18926929 |
| Type Disp | Equity |
| Volume | 102,243 |
| Website | https://www.dermatarx.com |
| Zip | 92,130 |